How Long Does Wellbutrin SR Stay in Your System?

Wellbutrin SR (bupropion sustained-release) takes roughly eight days to fully leave your body after the last dose, though the parent drug itself clears much faster than that. The reason for the gap is that your liver converts bupropion into several active metabolites that linger far longer than the original molecule. The half-life of bupropion itself is about 21 hours, but its longest-lived metabolite has a half-life closer to 37 hours, and that metabolite is what stretches the total clearance window.

Half-Life of the Parent Drug

When you swallow a Wellbutrin SR tablet, peak blood levels occur around three hours later, thanks to the sustained-release coating that slows absorption compared to the immediate-release version.¹ From there, bupropion’s concentration starts to decline with a half-life of roughly 21 hours.¹ That means about half the parent drug is gone from your blood every 21 hours. After five half-lives, a drug is considered essentially eliminated, so bupropion itself clears in roughly four to five days.

You may see shorter half-life figures cited elsewhere, sometimes as low as 8 to 10 hours.² One older pharmacokinetic review reported an initial distribution phase of about 1.5 hours and a terminal elimination phase of about 14 hours.³ These differences reflect different study designs, formulations tested, and how the phases of elimination were defined. For practical purposes with the SR formulation, the roughly 21-hour figure from comprehensive pharmacokinetic modeling is the most useful number.

Why the Metabolites Matter More

Focusing only on bupropion itself misses the bigger picture. Your liver breaks bupropion down into three active metabolites, meaning they still have pharmacological effects in your body even after the parent drug is gone. The major one, hydroxybupropion, is formed by a liver enzyme called CYP2B6.⁴ The other two, threohydrobupropion and erythrohydrobupropion, are produced through separate chemical pathways in the liver and intestine.⁴

These metabolites don’t just hang around at low levels. At steady state (after you’ve been taking the drug regularly), the peak concentration of hydroxybupropion is four to seven times higher than bupropion’s own peak, and the total exposure is about ten times greater.¹ All three metabolites reach higher plasma concentrations than the parent drug.⁵ So in terms of what’s actually circulating through your blood and brain, the metabolites are doing most of the work, and they’re also the reason “how long it stays in your system” is a longer answer than the parent drug’s half-life alone would suggest.

How Long Each Metabolite Takes to Clear

Each metabolite has its own half-life, and they vary considerably:

Hydroxybupropion: about 20 hours, similar to the parent drug.
Erythrohydrobupropion: about 33 hours on average.
Threohydrobupropion: about 37 hours on average, making it the slowest to leave.

All three figures come from the same pharmacokinetic analysis of bupropion’s formulations.¹ Applying the five-half-life rule to threohydrobupropion gives a clearance window of roughly 7.5 to 8 days. That is the practical answer for most healthy adults: after about a week and a half, even the most persistent metabolite should be at negligible blood levels.

One pharmacokinetic study using detailed stereoselective analysis found terminal half-lives of bupropion’s metabolites ranging from about 7 to 46 hours, depending on which mirror-image form of the molecule was measured.⁶ That 46-hour upper end suggests some molecular forms could take even longer to clear. For a reasonable general estimate, though, eight to ten days after your last SR dose covers the vast majority of people.

Who Clears It Slower

Several factors can stretch that timeline. The most significant are genetics, kidney function, and age.

Genetic Variation in CYP2B6

The CYP2B6 enzyme responsible for forming hydroxybupropion comes in different genetic versions. Some people carry gene variants (specifically CYP2B6*6 and *18) that reduce hydroxybupropion production by about a third.⁷ In that same study, genotype plus sex explained about half of the total variation in hydroxybupropion levels between individuals.⁷ This means someone who is a slow metabolizer may have less hydroxybupropion circulating but could have more unchanged bupropion lingering for longer, since the drug isn’t being converted as efficiently. These genetic differences are invisible to you unless you’ve had pharmacogenomic testing, but they’re a real reason why two people taking the same dose can have meaningfully different clearance timelines.

Kidney Problems

Bupropion is processed in the liver, but the metabolites are eliminated partly through the kidneys. In people with significant kidney impairment, bupropion’s blood levels were roughly double those in healthy controls, and the half-life of the parent drug was about 140% longer.⁸ The ratio of metabolites to parent drug also shifted downward, suggesting the metabolites themselves accumulate differently when the kidneys aren’t working well.⁸ If you have kidney disease, the drug and its metabolites could stay in your system substantially longer than the general estimates.

Older Adults

Age introduces its own complications. A study of elderly patients with depression found that the metabolite half-lives after a single dose were already on the long side: about 34 hours for hydroxybupropion, about 39 hours for threohydrobupropion, and about 61 hours for erythrohydrobupropion.⁹ That erythrohydrobupropion figure is nearly twice as long as the average in younger adults. With repeated dosing, some elderly patients showed disproportionate accumulation of metabolites, meaning levels climbed higher than expected.⁹ In an older adult, full clearance after stopping Wellbutrin SR could take two weeks or more rather than the eight to ten days typical for younger, healthy individuals.

Brain Effects Can Outlast Blood Levels

Something that catches many people off guard is that even after the drug is undetectable in blood, its effects on the brain may persist. Bupropion and hydroxybupropion block the dopamine transporter (DAT), which is part of how the drug works as an antidepressant and smoking-cessation aid. One imaging study found that three hours after the last dose of Wellbutrin SR, about 26% of dopamine transporters were still occupied, and that level of occupancy was maintained through 24 hours.¹⁰

More striking, a clinical case report found that bupropion’s effect on dopamine transporter binding was still robust a full week after the drug was discontinued.¹¹ The researchers suggested this might reflect longer-term adaptive changes in dopamine transmission rather than just the physical presence of the molecule. This is worth knowing if you’re stopping the medication and wondering when you’ll feel “back to baseline.” Blood clearance and brain clearance aren’t the same thing, and the brain’s adjustment likely takes longer.

False Positive Drug Tests

If you’re subject to urine drug screening for employment or other reasons, this is one of the most practically important things to know about Wellbutrin SR’s metabolites. Bupropion and its metabolites can trigger false positive results for amphetamines on certain immunoassay-based screening tests. One study at a Veterans Affairs medical center examined urine samples that initially screened positive for amphetamines but failed to confirm on more precise testing. Among those false positives, 41% came from patients who were prescribed bupropion, making it the single most common cause of false positive amphetamine screens in that population.¹²

Laboratory research has confirmed the mechanism: at least two commonly used immunoassay kits cross-react with bupropion metabolites when those metabolites are present above certain concentrations. In tested cases, samples flagged positive for amphetamine contained no actual amphetamines when checked with precise confirmation methods, but they did contain bupropion and its metabolites.¹³ Because the metabolites persist for over a week, this risk doesn’t vanish the day after your last pill. If you’re asked to take a drug test, let the testing facility know you take bupropion. A confirmatory test using mass spectrometry can easily distinguish bupropion metabolites from actual amphetamines.

Wellbutrin SR in Breast Milk

For nursing parents, clearance from breast milk is a separate question from blood clearance. After a single 100-milligram dose, bupropion’s peak concentration in breast milk occurred around two hours, and the milk-to-plasma ratio ranged from about 2.5 to 8.6 over six hours, meaning the drug concentrated in milk at levels well above what was in the blood.¹⁴ Two of the three metabolites were also detected in breast milk. However, in the infant’s blood sample, neither bupropion nor any of its metabolites were detectable.¹⁴ That’s a small sample, so it doesn’t settle the safety question entirely, but it suggests the infant’s actual exposure may be minimal even when milk levels are measurable. Anyone weighing this decision should discuss it with their prescriber, because the milk-to-plasma ratios are high enough to warrant attention even though the infant blood levels in available data were reassuringly low.

SR Versus Other Bupropion Formulations

Wellbutrin comes in three formulations: immediate-release (IR), sustained-release (SR), and extended-release (XL). They all contain the same active ingredient, so the metabolites and their half-lives are identical. The difference is how quickly the drug gets absorbed. The IR version reaches peak blood levels fastest, in roughly 1.5 hours. The SR version peaks at about 3 hours. The XL version takes the longest, peaking around 5 hours.¹

Because the XL version delays absorption further, its effective duration in the body is slightly longer on the front end, meaning the clock on clearance starts a bit later. But once the drug is absorbed, all three formulations follow the same metabolic pathways and produce the same metabolites at the same half-lives. The total clearance time difference between SR and XL is probably on the order of hours, not days. The IR formulation might clear a touch faster at the very beginning, but the metabolites still dominate the tail end regardless of which tablet you took.

What Happens in Overdose

In overdose situations, the pharmacokinetics change dramatically. Sustained-release tablets taken in large quantities can form a mass in the stomach that continues releasing drug for far longer than a single therapeutic dose would. One fatal overdose case documented extremely high levels of the metabolite threohydrobupropion in blood and urine, with blood concentrations of the parent drug reaching 1.9 milligrams per liter and the highest tissue concentrations found in the liver.¹⁵ When a mass of undissolved tablets forms in the gut, the drug continues to be absorbed unpredictably for an extended period, making the normal half-life estimates useless for predicting clearance. This is relevant for emergency physicians rather than typical patients, but it underscores why sustained-release formulations deserve extra caution in overdose settings.

Putting the Timeline Together

If you stop taking Wellbutrin SR and want a rough calendar:

Day 1: Parent bupropion levels drop by about half. Metabolite levels begin declining too, but they started from much higher concentrations.
Days 3 to 5: Bupropion itself is mostly gone from your blood. Hydroxybupropion is nearing negligible levels. The two slower metabolites are still measurable.
Days 7 to 10: Threohydrobupropion and erythrohydrobupropion reach negligible blood levels in most healthy younger adults.
Beyond day 10: Older adults, people with kidney impairment, or individuals with certain CYP2B6 gene variants may still have measurable metabolite levels. Brain effects on dopamine signaling may persist independently of blood levels.

These are estimates from pharmacokinetic studies of typical populations. Your own clearance will depend on the factors discussed above. If you’re stopping the medication and notice lingering effects like changes in mood or sleep, the metabolite timeline and the brain’s own adjustment period help explain why those effects can take a couple of weeks to fully resolve, even though the parent drug is technically gone within days.

1
Clinical Therapeutics. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations
2
Psychopharmacology Institute. Antidepressant Basics Part 1: SSRIs and Bupropion – Section: Pharmacokinetics
3
PubMed. Clinical pharmacokinetics of bupropion: a review
4
PubMed Central. Metabolism of bupropion by carbonyl reductases in liver and intestine
5
PubMed. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects
6
The Journal of Pharmacology and Experimental Therapeutics. Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers
7
PubMed Central. Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state
8
PubMed Central. Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites
9
PubMed. Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression
10
PubMed. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography
11
PubMed Central. Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism
12
PubMed Central. Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay
13
Therapeutic Drug Monitoring. Crossreactivity of Bupropion Metabolite With Enzyme-Linked Immunosorbent Assays Designed to Detect Amphetamine in Urine
14
PubMed Central. Excretion of bupropion in breast milk
15
PubMed Central. Bupropion Overdose Resulted in a Pharmacobezoar in a Fatal Bupropion (Wellbutrin) Sustained-release Overdose: Postmortem Distribution of Bupropion and its Major Metabolites